Modulight Spotlights: LASER-SHARP RESEARCH – October 2025
This month we are highlighting exciting findings by S. Takao et al. from Hisataka Kobayashi’s lab at the National Cancer Institute, NIH. Published in Cancer Letters, the study shows that near-infrared photoimmunotherapy can destroy cancer cells by targeting intercellular adhesion molecule-1. Because the molecule is found in many different cancers, this approach may offer a broadly applicable, tumor-agnostic therapy. Activated with an ML7710 laser, the treatment produced strong antitumor effects against breast cancer, oral cancer, and myeloma. Importantly, therapy stimulated strong antitumor immune response through activation and accumulation of T cells in the tumor area.
Modulight is very happy to be supporting this research. We would like to deliver our warmest congratulations to the research team!
#Laser-Sharp Research #photoimmunotherapy #immunotherapy #breastcancer #oralcancer #myeloma #preclinical
About Modulight’s LASER-SHARP RESEARCH concept:
Laser-Sharp Research is a concept where our scientific board highlights cutting-edge scientific research articles from our customers. Important selection criteria are that Modulight and laser product are mentioned in the publication, the impact and relevance of the results, clinical translatability, as well as scientific quality of the journal. The nominated research groups will be rewarded to encourage the great work done.
Contact Us
Do you have questions or comments related to this LASER-SHARP RESEARCH nomination? Maybe your group has done significant research that you would like us to spotlight? Or would you like to request literature? Please drop us a line!